A psychosocial perspective of medication side effects, experiences, coping approaches and implications for adherence in hypertension management
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Introduction: This study examined whether psychosocial variables influenced patients’ perception and experience of side effects of their medicines, how they coped with these experiences and the impact on medication adherence behaviour. Methods: A hospital-based mixed methods study using quantitative and qualitative approaches was conducted with hypertensive patients. Participants were asked about side effects, medication adherence, common psychological symptoms and coping mechanisms with the aid of standard questionnaires and an interview guide. Results: The experiences of side effects—such as palpitations, frequent urination, recurrent bouts of hunger, erectile dysfunction, dizziness, cough, physical exhaustion—were categorized as no/low (39.75 %), moderate (53.0 %) and high (7.25 %). Significant relationships between depression (x2 = 24.21, p < 0.0001), anxiety (x2 = 42.33, p < 0.0001), stress (x2 = 39.73, p < 0.0001) and side effects were observed. A logistic regression model using the adjusted results for this association is reported—depression [OR = 1.9 (1.03–3.57), p = 0.04], anxiety [OR = 1.5 (1.22–1.77), p ≤ 0.001] and stress [OR = 1.3 (1.02–1.71), p = 0.04]. Side effects significantly increased the probability of individuals to be non-adherent [OR = 4.84 (95 % CI 1.07–1.85), p = 0.04] with social factors, media influences and attitudes of primary care givers further explaining this relationship. Personal adoption of medication modifying strategies, espousing the use of complementary and alternative treatments and interventions made by clinicians were the main forms of coping with side effects. Discussion: Results from this study show that, in addition to a biomedical approach, the experience of side effects has biological, social and psychological interrelations. The results offer more support for the need for a multi-disciplinary approach to healthcare where all forms of expertise are incorporated into health provision and patient care.
Abstract
Introduction: This study examined whether psychosocial variables influenced patients’ perception and experience of side effects of their medicines, how they coped with these experiences and the impact on medication adherence behaviour. Methods: A hospital-based mixed methods study using quantitative and qualitative approaches was conducted with hypertensive patients. Participants were asked about side effects, medication adherence, common psychological symptoms and coping mechanisms with the aid of standard questionnaires and an interview guide. Results: The experiences of side effects—such as palpitations, frequent urination, recurrent bouts of hunger, erectile dysfunction, dizziness, cough, physical exhaustion—were categorized as no/low (39.75 %), moderate (53.0 %) and high (7.25 %). Significant relationships between depression (x2 = 24.21, p < 0.0001), anxiety (x2 = 42.33, p < 0.0001), stress (x2 = 39.73, p < 0.0001) and side effects were observed. A logistic regression model using the adjusted results for this association is reported—depression [OR = 1.9 (1.03–3.57), p = 0.04], anxiety [OR = 1.5 (1.22–1.77), p ≤ 0.001] and stress [OR = 1.3 (1.02–1.71), p = 0.04]. Side effects significantly increased the probability of individuals to be non-adherent [OR = 4.84 (95 % CI 1.07–1.85), p = 0.04] with social factors, media influences and attitudes of primary care givers further explaining this relationship. Personal adoption of medication modifying strategies, espousing the use of complementary and alternative treatments and interventions made by clinicians were the main forms of coping with side effects. Discussion: Results from this study show that, in addition to a biomedical approach, the experience of side effects has biological, social and psychological interrelations. The results offer more support for the need for a multi-disciplinary approach to healthcare where all forms of expertise are incorporated into health provision and patient care.
참고문헌 (26)
- Addo J., "Review of population-based studies on hypertension in Ghana", Ghana Med J., 46(2 Suppl), pp.4~11 (2012)
- Kearney PM., "Global trends of hypertension analysis of worldwide data", Lancet, 365, pp.217~223 (2005)
- Lim SS., "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions., 1990–2010 : a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380(9859), pp.2224~2260 (2012)
- Novo S., "Role of ARBs in the blood hypertension therapy and prevention of cardiovascular events", Curr Drug Targets, 10(1), pp.20~25 (2009)
- Ministry of Health., "Standard treatment guidelines. 6th ed", pp.96~122 (2010), Yamens Press
- Walker R, "Clinical pharmacy and therapeutics. 4th ed", pp.265~271 (2007), Churchill Livingstone
- Etienne M., "Indicators of adherence to antiretroviral therapy treatment among HIV", AIDS patients in 5African countries, 2010, pp.9, 98~
- Ho M., "Medication adherence : its importance in cardiovascular outcomes", Circulation, 119, pp.3028~3035 (2009)
- Krousel-Wood MA., "Hypertension and depression : co-existing barriers to medication adherence", J Clin Hypertens, 12(7), pp.481~486 (2010)
- Svensson S., "Adverse events and patients’ perceptions of antihypertensive drug effectiveness", J Hum Hypertens, 17, pp.671~675 (2003)
- Naing L., "Practical issues in calculating the sample size for prevalence studies", Arch Orofac Sci, 1, pp.9~14 (2006)
- Lovibond SH, "Manual for the depression anxiety stress scales" (1995), Psychology Foundation
- Morisky DE., "Predictive validity of a medication adherence measure in an outpatient setting", J Clin Hypertens, 10(5), pp.348~354 (2008)
- Morgado M., "Predictors of uncontrolled hypertension and antihypertensive medication nonadherence", J Cardiovasc Dis Res, 1(4), pp.196~202 (2010)
- Osterberg L., "Adherence to medication", N Engl J Med, 353, pp.5~ (2005)
- Recker RR., "Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women", Mayo Clin Proc, 80(7), pp.856~861 (2005)
- Buabeng KO., "Unaffordable drug prices : the major cause of non-compliance with hypertension medication in Ghana", J Pharm Pharmaceut Sci, 7(3), pp.350~352 (2004)
- Proulx M., "Social context, the struggle with uncertainty, and subjective risk as meaning-rich constructs for explaining HBP noncompliance", Patient Educ Couns, 68, pp.98~106 (2007)
- Viswanathan H., "An inquiry into medication meanings, illness, medication use, and the transformative potential of chronic illness among African Americans with hypertension", Res Soc Adm Pharm, 1, pp.21~39 (2005)
- Nair KV., "Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey", Patient Prefer Adherence, 5, pp.195~206 (2011)
- Swartz L., "Fertility transition in South Africa and its impact on the four major racial groups. In: Department of Social Development", Current South African issues of poverty, HIV, 2003, 7~26[DOI]
- Chesney MA., "Adherence to HIV combination therapy", Soc Sci Med, 20(11), pp.1599~1605 (2000)
- Watt MH., ""It’s all the time in my mind" : facilitators of adherence to antiretroviral therapy in a Tanzanian setting", Soc Sci Med, 68(10), pp.1793~1800 (2009)
- Goodfellow NA., "What the newspapers say about medication adherence : a content analysis", BMC Public Health, 13, pp.909~ (2013)
- Vetere G., "Prevalence of anxiety disorders in patients with essential hypertension", Vertex, 18(71), pp.20~25 (2007)
- Kretchy IA., "Patterns and determinants of the use of complementary and alternative medicine : a cross-sectional study of hypertensive patients in Ghana", BMC Complement Altern Med, 14, pp.44~ (2014)